Incyte's Change in Accured Expenses rose 676.28% to $138.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$148.2 million, marking a year-over-year decrease of 15313.06%. This contributed to the annual value of -$148.2 million for FY2025, which is 15313.06% down from last year.
As of Q4 2025, Incyte's Change in Accured Expenses stood at $138.5 million, which was up 676.28% from $115.1 million recorded in Q3 2025.
In the past 5 years, Incyte's Change in Accured Expenses registered a high of $138.5 million during Q4 2025, and its lowest value of -$476.7 million during Q2 2025.
Moreover, its 5-year median value for Change in Accured Expenses was $62.8 million (2022), whereas its average is $35.6 million.
In the last 5 years, Incyte's Change in Accured Expenses surged by 243045.93% in 2022 and then crashed by 51089.61% in 2025.
Quarter analysis of 5 years shows Incyte's Change in Accured Expenses stood at $46.4 million in 2021, then grew by 3.04% to $47.8 million in 2022, then skyrocketed by 143.08% to $116.2 million in 2023, then rose by 11.66% to $129.8 million in 2024, then increased by 6.76% to $138.5 million in 2025.
Its last three reported values are $138.5 million in Q4 2025, $115.1 million for Q3 2025, and -$476.7 million during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value